Ellington Management Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-2,400
Closed -$222K – 721
2019
Q4
$222K Buy
+2,400
New +$202K 0.05% 417
2014
Q3
– Sell
-14,100
Closed -$321K – 445
2014
Q2
$321K Buy
14,100
+300
+2% +$5.34K 0.15% 207
2014
Q1
$177K Sell
13,800
-25,700
-65% -$369K 0.05% 547
2013
Q4
$539K Sell
39,500
-4,900
-11% -$58.5K 0.19% 166
2013
Q3
$492K Buy
44,400
+4,100
+10% +$40.8K 0.09% 320
2013
Q2
$332K Buy
+40,300
New +$338K 0.06% 474

Other funds holding RGEN

Ellington Management Group's RGEN Position: Q1 2020 in Review

Ellington Management Group sold out of Repligen (RGEN) in Q1 2020, closing a stake of 2,400 shares — an estimated $222K sold.

Ellington Management Group first reported a position in RGEN in Q2 2013 and held it in 6 quarters. The position peaked at $539K in Q4 2013. 309 funds tracked by Wall St. Rank hold RGEN as of Q1 2020.

  • Ellington Management Group reported no remaining Repligen position as of Q1 2020 after selling out during the quarter.
  • Ellington Management Group sold 2,400 Repligen shares in Q1 2020, an estimated $222K.
  • Ellington Management Group first reported a position in Repligen in Q2 2013 and held it in 6 quarters.
  • Ellington Management Group's Repligen position peaked at $539K in Q4 2013.
  • 309 funds tracked by Wall St. Rank held Repligen as of Q1 2020.

Based on Ellington Management Group's 13F filing for Q1 2020, filed 15 May 2020.